BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12461709)

  • 21. Journalists, district attorneys and researchers: why IRBs should get in the middle.
    Chodos AH; Lee SJ
    BMC Med Ethics; 2015 Mar; 16():19. PubMed ID: 25889147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
    Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
    Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IRB paradox: could the protectors also encourage deceit?
    Keith-Spiegel P; Koocher GP
    Ethics Behav; 2005; 15(4):339-49. PubMed ID: 16578924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disclosing conflicts of interest to research subjects: an ethical and legal analysis.
    Resnik DB
    Account Res; 2004; 11(2):141-59. PubMed ID: 15675055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.
    Dyrbye LN; Thomas MR; Mechaber AJ; Eacker A; Harper W; Massie FS; Power DV; Shanafelt TD
    Acad Med; 2007 Jul; 82(7):654-60. PubMed ID: 17595560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of institutional review board practice variation on observational health services research.
    Green LA; Lowery JC; Kowalski CP; Wyszewianski L
    Health Serv Res; 2006 Feb; 41(1):214-30. PubMed ID: 16430608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: from experimental design to institutional review board approval.
    Vaslef SN; Cairns CB; Falletta JM
    Arch Surg; 2006 Oct; 141(10):1019-23; discussion 1024. PubMed ID: 17043281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current issues in clinical research and the development of new pharmaceuticals.
    Goldhammer A
    Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Nature of IRB Contingencies Required for Informed Consent Document Approval.
    Blackwood RA; Maio RF; Mrdjenovich AJ; VandenBosch TM; Gordon PS; Shipman EL; Hamilton TA
    Account Res; 2015; 22(4):237-45. PubMed ID: 25897768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical issues in health care institutions. Lesson five: Research ethics.
    Bach S; Hartline JV
    Radiol Manage; 1991; 13(4):27-33. PubMed ID: 10115834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 32. Conflict + interest: financial incentives and informed consent in human subject research.
    Benbow S
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
    [No Abstract]   [Full Text] [Related]  

  • 33. The purpose, composition, and function of an institutional review board: balancing priorities.
    Enfield KB; Truwit JD
    Respir Care; 2008 Oct; 53(10):1330-6. PubMed ID: 18811996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?
    Burris S; Davis C
    Am J Bioeth; 2009 Nov; 9(11):48-54. PubMed ID: 19882460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A plea for pragmatism in clinical research ethics.
    Brendel DH; Miller FG
    Am J Bioeth; 2008 Apr; 8(4):24-31. PubMed ID: 18576248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health service research: the square peg in human subjects protection regulations.
    Gittner LS; Roach MJ; Kikano G; Grey S; Dawson NV
    J Med Ethics; 2011 Feb; 37(2):118-22. PubMed ID: 21071571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
    Jansson RL
    Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing invitations to participate in clinical research: preliminary versus informed consent.
    Iltis AS
    J Med Philos; 2005 Feb; 30(1):89-106. PubMed ID: 15814369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. U.S. Federal Regulations for emergency research: a practical guide and commentary.
    McRae A; Weijer C
    Acad Emerg Med; 2008 Jan; 15(1):88-97. PubMed ID: 18211320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IRB reformation: is unfettered access the answer?
    Florczak KL; Lockie NM
    Nurs Sci Q; 2015 Jan; 28(1):13-7. PubMed ID: 25520457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.